Skip to main content
. 2014 May 20;12:81. doi: 10.1186/1741-7015-12-81

Figure 2.

Figure 2

The urinary suPAR levels in primary FSGS patients with different pathological variants. FSGS, focal segmental glomerulosclerosis; suPAR, soluble urokinase receptor.